We have an increasing number of project teams, both from within and outside the University, who have successfully used the Reality Emulator to inform their work and engage with their stakeholders.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced the Phase 2 LATTICE-UC study evaluating deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) ...